PB: Methodology, Writing review & editing, Writing original draft, Conceptualization, Project administration, Visualization, Resources, Formal analysis
Ozempic (which is prescribed to treat type 2 diabetes but can also be taken off-label to aid with weight loss) and its sister drug, Wegovy (which is prescribed as an anti-obesity treatment), use the same medication, semaglutide
References Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity (OASIS 4) , New England Journal of Medicine, 2025 [Accessed 20 April 2026] Oral Semaglutide 50 mg Taken Once Per Day in Adults with Overweight or Obesity (OASIS 1) , The Lancet, 2023 [Accessed 20 April 2026] Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) , New England Journal of Medicine, 2021 [Accessed 20 April 2026] Once-Weekly Semaglutide 7.2 mg in Adults with Obesity (STEP UP) , The Lancet Diabetes & Endocrinology, 2025 [Accessed 24 April 2026] Weight Regain and Cardiometabolic Effects After Withdrawal of Semaglutide: The STEP 1 Trial Extension , Diabetes, Obesity and Metabolism, 2022 [Accessed 20 April 2026] Clinical Pharmacokinetics of Oral Semaglutide: Analyses of Data from Clinical Pharmacology Trials , Clinical Pharmacokinetics, 2021 [Accessed 20 April 2026] Wegovy 2.4 mg, FlexTouch Solution for Injection in Pre-filled Pen Summary of Product Characteristics , Electronic Medicines Compendium, 2025 [Accessed 20 April 2026] GLP-1 and dual GLP-1/GIP receptor agonists: strengthened warnings on acute pancreatitis , Medicines and Healthcare products Regulatory Agency, 2026 [Accessed 16 June 2026]
They provide information on the availability and prices of medications in various cities in India, such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, and Pune
It has been approved for weight loss by the MHRA
